Furthermore, to study the aggressive nature of tumours associated with high G9a expression reported previously, we showed that depleting G9a in HCC can also reduce the proliferative, invasive and migration abilities of cancer cells [13, 14, 20]. The gene discussed is EHMT2; the disease is cancer.